Second-degree relative donors for T-replete haploidentical allogeneic stem cell transplantation with high-dose post-transplant cyclophosphamide: toward crossing the major HLA barrier

Bone Marrow Transplant. 2017 Jul;52(7):1063-1064. doi: 10.1038/bmt.2017.60. Epub 2017 Apr 3.

Authors

A Garnier¹, T Guillaume¹, P Peterlin¹, M C Béné², Y Le Bris², V Dubruille¹, B Mahé¹, T Gastinne¹, C Touzeau¹, N Blin¹, S Le Gouill¹, P Moreau¹, P Chevallier¹

Affiliations

¹ Department of Hematology, Nantes University Hospital, Nantes, France.
² Department of Hematology/Biology, Nantes University Hospital, Nantes, France.

PMID: 28368382
DOI: 10.1038/bmt.2017.60

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Allografts
Cyclophosphamide / administration & dosage*
Family
Female
HLA Antigens*
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
Lymphoma, B-Cell / pathology
Lymphoma, B-Cell / therapy*
Male
Middle Aged
Stem Cell Transplantation*
Tissue Donors*

Substances

HLA Antigens
Cyclophosphamide